Remifentanil hameln 5 mg prašak za koncentrat za otopinu za injekciju/infuziju
Name | Remifentanil hameln 5 mg prašak za koncentrat za otopinu za injekciju/infuziju |
---|---|
Marketing Authorisation Number | HR-H-013761777 |
Active Substance | remifentanilklorid |
Composition | svaka bočica sadrži remifentanilklorid što odgovara 5 mg remifentanila svaki ml otopine za injekciju/infuziju sadrži 1 mg remifentanila nakon rekonstitucije |
Pharmaceutical Form | Prašak za koncentrat za otopinu za injekciju / infuziju |
Manufacturer | hameln rds s.r.o., Modra, Slovačka
Siegfried Hameln GmbH, Hameln, Njemačka |
Marketing Authorisation Holder | hameln pharma gmbH, Inselstrasse 1, Hameln, Njemačka |
Marketing Authorisation Date | 04.02.2022 |
MA Period of Validity | 04.02.2027 |
Classification Number | UP/I-530-09/21-01/151 |
Registration Number | 381-12-01/154-22-03 |
Prescription | na recept |
Type of prescription | poseban i ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | N01AH06 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |
Summary of risk management plan | download |